Every pancreatic cancer patient is different. Patients who receive treatment based on their biology can live longer. The Pancreatic Cancer Action Network strongly recommends all pancreatic cancer patients get genetic testing for inherited mutations as soon as possible after diagnosis and biomarker testing of their tumor tissue to help determine the best treatment options. Patients should discuss both tests with their care team. The tests can be available through their treating institution or PanCAN’s Know Your Tumor® precision medicine service. Genetic testing for inherited mutations can also inform family members of risk regardless of family history.
It is important to consider this information because a treatment that works well for one person may not work as well for someone else. Knowing the mutations in your tumor or body will help you and your healthcare team select treatment options – including clinical trials – that are likely to work best for you and may not have been considered otherwise. Know Your Tumor reports provide valuable insight to help support the treatment decisions you make with your healthcare team.
Your healthcare team will work with Tempus to submit a tissue sample for biomarker testing (as well as a blood or saliva sample, if you choose to get genetic testing for inherited mutations). Once Tempus receives the tumor tissue, please allow 14 days for the complete report of personalized treatment options to be emailed to your doctor.
Medical procedures – including biopsies – will be billed to the patient’s insurance. The patient will be responsible for any co-pay, co-insurance or insurance deductible associated with a procedure to obtain tumor tissue.
Should insurance coverage issues arise, our Know Your Tumor CareLine (in partnership with the Patient Advocate Foundation) may be able to help.